Current Pharmaceutical Design
Country
United Arab Emirates
Middle East
Subject Area and Category
Pharmacology, Toxicology and Pharmaceutics
└
Drug Discovery
Q2
└
Pharmacology
Q2
Publisher
SJR 2025
0.632
Q2
SJR Score
H-Index
197
Citations / Doc (2yr)
3.35
Total Docs. (latest)
325
Total Citations (3yr)
3,057
Publication type
Journals
ISSN
13816128, 18734286
Coverage
1995-2026
Journal Rank
#9,307
Subject Categories
Drug Discovery
Q2
Pharmacology
Q2
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 325 |
| Total Docs. (3 years) | 899 |
| Total Refs. | 33,476 |
| Total Citations (3 years) | 3,057 |
| Citable Docs. (3 years) | 827 |
| Citations / Doc. (2 years) | 3.35 |
| Ref. / Doc. | 103.00 |
| % Female | 40.6% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Current Pharmaceutical Design?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Current Pharmaceutical Design has an SJR of 0.632 and is ranked Q2.
What is the SJR and quartile of Current Pharmaceutical Design?
Current Pharmaceutical Design has an SJR (SCImago Journal Rank) of 0.632 and its best quartile is Q2.
What is the H-index of Current Pharmaceutical Design?
The H-index of Current Pharmaceutical Design is 197, meaning 197 of its articles have each been cited at least 197 times.
Is Current Pharmaceutical Design indexed in Scopus?
Yes. Current Pharmaceutical Design is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.